CORRECTION article

Front. Oncol., 01 March 2022

Sec. Pharmacology of Anti-Cancer Drugs

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.870805

Corrigendum: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis

  • BG

    Bochao Geng 1

  • YZ

    Yuanzhang Zhu 1

  • YY

    Yingying Yuan 2

  • JB

    Jingyi Bai 1

  • ZD

    Zhizhi Dou 1

  • AS

    Aihua Sui 3

  • WL

    Wenjuan Luo 1*

  • 1. Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China

  • 2. Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao, China

  • 3. Central Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China

In the original article, there was a mistake in Figure 7 as published. We recognized by ourselves that the image of the Ctrl siRNA group in OCM-1 cells was misused. The corrected Figure 7 appears below.

Figure 7

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

artesunate, choroidal melanoma, vasculogenesis mimicry, angiogenesis, VE-cadherin

Citation

Geng B, Zhu Y, Yuan Y, Bai J, Dou Z, Sui A and Luo W (2022) Corrigendum: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis. Front. Oncol. 12:870805. doi: 10.3389/fonc.2022.870805

Received

07 February 2022

Accepted

14 February 2022

Published

01 March 2022

Volume

12 - 2022

Edited and reviewed by

Jill Kolesar, University of Kentucky, United States

Updates

Copyright

*Correspondence: Wenjuan Luo,

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics